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Cation chloride cotransporters (CCC) play an essential role for neuronal chloride
homeostasis. K+-Cl− cotransporter (KCC2), is the principal Cl−-extruder, whereas Na+-
K+-Cl− cotransporter (NKCC1), is the major Cl−-uptake mechanism in many neurons. As
a consequence, the action of the inhibitory neurotransmitters gamma-aminobutyric acid
(GABA) and glycine strongly depend on the activity of these two transporters. Knowledge
of the mechanisms involved in ion transport and regulation is thus of great importance to
better understand normal and disturbed brain function. Although no overall 3-dimensional
crystal structures are yet available, recent molecular and phylogenetic studies and
modeling have provided new and exciting insights into structure-function relationships of
CCC. Here, we will summarize our current knowledge of the gross structural organization
of the proteins, their functional domains, ion binding and translocation sites, and the
established role of individual amino acids (aa). A major focus will be laid on the delineation
of shared and distinct organizational principles between KCC2 and NKCC1. Exploiting the
richness of recently generated genome data across the tree of life, we will also explore
the molecular evolution of these features.
Keywords: CCCs, structure, phosphorylation, oligomerization, evolution, modeling, APC superfamily, synaptic
inhibition
INTRODUCTION
The solute carrier 12 (SLC12) gene family encodes electroneutral,
secondary active cation-chloride cotransporters (CCCs). These
proteins are located in the plasma membrane and mediate the
symport of cations (Na+, K+) coupled with chloride (Cl−). The
transporters play a crucial role in various physiological processes
such as regulation of cell volume, directional ion transport across
epithelial cells, secretion of potassium, and regulation of intra-
cellular Cl−concentration in neurons (Payne et al., 2003; Adragna
et al., 2004; Gamba, 2005; Kahle et al., 2008; Blaesse et al., 2009; Di
Fulvio and Alvarez-Leefmans, 2009; Arroyo et al., 2013; Gagnon
and Delpire, 2013; Kaila et al., 2014). The importance of CCCs is
illustrated by their association with numerous human disorders
including Anderman’s syndrome, Gitelman’s syndrome, Bartter’s
syndrome (Simon et al., 1996; Kurtz et al., 1997; Vargas-Poussou
et al., 1998; Kunchaparty et al., 1999; De Jong et al., 2002; Howard
et al., 2002; Boettger et al., 2003; Gamba, 2005; Di Fulvio and
Alvarez-Leefmans, 2009; Gagnon and Delpire, 2013), epilepsy
(Rivera et al., 2002; Palma et al., 2006; Aronica et al., 2007;
Abbreviations: CCC, Cation chloride cotransporter; KCC, K+-Cl− cotrans-
porter; NKCC, Na+-K+-Cl− cotransporter; NCC, Na+, Cl− cotransporter;
GABA, gamma-aminobutyric acid; SLC, solute carrier family; TM, transmem-
brane domain; ECL, extracellular loop; ICL, intracellular loop; wt, wild type;
aa, amino acids; LEL, large extracellular loop.
Huberfeld et al., 2007; Kahle et al., 2014; Puskarjov et al., 2015),
neuropathic pain (Coull et al., 2003), spasticity (Boulenguez et al.,
2010), brain trauma (Shulga et al., 2008), deafness (Boettger
et al., 2002, 2003), autism (Lemonnier and Ben-Ari, 2010; Tyzio
et al., 2014), and schizophrenia (Kim et al., 2012; Morita et al.,
2014).
The SLC12 gene family belongs to the amino-acid-polyamine-
organocation (APC) superfamily (Hediger et al., 2004, 2013;
Höglund et al., 2011; Arroyo et al., 2013). Phylogenetic analyses
suggest that gene duplication events—one likely occurring at
the base of archeans and two at the base of eukaryotes—led
to the diversification and neofunctionalization of paralogs CCC
subfamilies (Hartmann et al., 2014). These subfamilies include
the K+-Cl− outward cotransporters (KCCs), Na+-K+-Cl− inward
cotransporters (NKCCs) and Na+-Cl− inward cotransporters
(NCCs), the polyamine transporter (CCC9), and the CCC inter-
acting protein (CIP1; Gamba, 2005; Daigle et al., 2009; Di Fulvio
and Alvarez-Leefmans, 2009; Arroyo et al., 2013; Gagnon and
Delpire, 2013; Hartmann et al., 2014). The status of CCC9
as a true CCC member remains equivocal (Hartmann et al.,
2014).
Additional whole genome duplication (2R hypothesis) and
independent gene duplication events at the base of vertebrates
led to their subfunctionalization into paralogs KCC (KCC1–4),
NKCC (NKCC1+2) and NCC (all vertebrates), NCC2 (teleost
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fish) and NCC3 (amphibian and squamates) isoforms (Gagnon
and Delpire, 2013; Hartmann et al., 2014). The presence of
the additional teleost-specific NCC2 clade is probably due to
an independent gene duplication event in the teleost fish lin-
eage (Hiroi et al., 2008; Wang et al., 2009; Hartmann et al.,
2014). Subsequent gene loss events resulted in the absence
of KCC3 in birds, KCC4 in amphibians, and NCC3 in birds
and mammals (Gagnon and Delpire, 2013; Hartmann et al.,
2014). Similarly, multiple gene loss events at the base of ver-
tebrates caused lack of CIP1 and CCC9 in extant vertebrates
(Hartmann et al., 2014). In this review we will focus on the
structure-function relationships of KCCs and NKCC/NCCs to
delineate shared and distinct organizational principles. We will
focus on KCC2 and NKCC1, as they are the main contrib-
utors to neuronal Cl− homeostasis. Data from other fam-
ily members will be included when they provide instructive
information.
OVERVIEW OF THE GENERAL CCC STRUCTURE
Proteins with a common evolutionary origin share a protein
identity of ∼30% and often a similar structure and function
(Murzin et al., 1995). This holds also true for the paralogs sub-
family members KCCs and NKCCs that share a protein identity
of ∼25% and a similar structural organization (Gamba, 2005; Di
Fulvio and Alvarez-Leefmans, 2009). As no X-ray structure of any
full-length family member has been obtained so far, our current
knowledge of their structural organization relies on biochemical
and computational analyses. Hydrophobicity profiles according
to the algorithm of Kyte-Doolittle (Kyte and Doolittle, 1982)
suggest 12 transmembrane domains (TMs), flanked by intracel-
lularly located N- and C-termini (Payne et al., 1996; Gerelsaikhan
and Turner, 2000; Gamba, 2005). The number of predicted
TMs (10–13), however, varies among different prediction algo-
rithms (Gerelsaikhan and Turner, 2000; Di Fulvio and Alvarez-
Leefmans, 2009). Experimental in vivo and in vitro analyses with
deletion mutants of predicted TMs demonstrated that NKCC1
consists of 12 TM helices and intracellularly located termini
(Gerelsaikhan and Turner, 2000; Gerelsaikhan et al., 2006). In
addition, several extracellular loops (ECL) were confirmed by
insertion of HA-tags in the ECL2 of KCC2, and ECL2, 3 and 4
of NKCC1 (Zhao et al., 2008; Acton et al., 2012; Somasekharan
et al., 2012; Weber et al., 2014). A notable structural difference
between KCCs and NKCC/NCCs concerns the position of a
long extracellular loop (LEL) that is situated between TM5 and
TM6 in KCCs, and between TM7 and TM8 in NKCCs/NCCs
(Gamba, 2005). Several N-linked glycosylation sites have been
identified in this LEL, which confirms its extracellular location
(Hoover et al., 2003; Paredes et al., 2006; Weng et al., 2013).
The intracellular location of various regulatory phospho-sites,
targeted by cytoplasmic kinases and phosphatases, is also in full
agreement with the current structural model (Rinehart et al.,
2009; Monette and Forbush, 2012; Rosenbaek et al., 2014; Weber
et al., 2014).
TMs are highly conserved among paralogs KCCs (74–80%
identity) and NKCCs/NCCs isoforms (59–79% identity), likely
due to their critical role in ion translocation (Payne et al., 1995,
1996; Isenring and Forbush, 2001; Gamba, 2005; Somasekharan
et al., 2012). A similar degree of sequence conservation is observed
for the C-terminus (KCC isoforms: 67–81%, NKCC/NCC iso-
forms: 48–56%). In contrast, the N-terminus is much more vari-
able among paralogs KCCs (33–50% identity) and NKCC/NCC
isoforms (13–28% identity) (Gamba, 2005). This terminus is,
however, highly conserved among orthologous vertebrate fam-
ily members (CCC sequences of the same isoform from fish
to human), indicating a shared function of the N-terminus in
orthologs. N-terminal splice variants of KCC1, 2, 3, as well as N-
and C-terminal chimera of orthologous shark and human NKCC1
(74% protein identity) reveal that the termini are not involved
in ion translocation and binding of loop diuretics (Isenring and
Forbush, 1997, 2001; Tovar-Palacio et al., 2004; Mercado et al.,
2005, 2006; Uvarov et al., 2007; Payne, 2009). Their main function
therefore is regulation of transport activity by harboring sites for
posttranslational modifications like phosphorylation (Rinehart
et al., 2009; Monette et al., 2014; Weber et al., 2014). Furthermore,
they contain structural motifs that are important for features such
as isotonic activity of KCC2 (Bergeron et al., 2006; Mercado et al.,
2006; Acton et al., 2012). The termini also partake in regulation
of membrane expression (Lee et al., 2007, 2010; Zhao et al.,
2008; Zaarour et al., 2012; Rosenbaek et al., 2014), basolateral
and apical sorting in polarized cells (Carmosino et al., 2008) and
oligomerization (Casula et al., 2001, 2009; Simard et al., 2004;
Brunet et al., 2005; Parvin et al., 2007; Warmuth et al., 2009).
At present, the only available X-ray based structure is that
of the C-terminus of the ancestral archean Methanosarcina ace-
tivorans CCC (maCCC; Warmuth et al., 2009). According to the
alignment of Warmuth et al. (2009), the maCCC C-terminus
shares a protein identity of 12% to human KCC2 (hsKCC2) and
11.6% to human NKCC1 (hsNKCC1). This C-terminus consists
of a mixed α/ß fold and two structurally related subdomains
(Warmuth et al., 2009). Each subdomain is structured into a
central five-stranded parallel ß sheet that is mostly connected via
α-helices. The two five-stranded parallel ß sheets are orientated in
an inverted repeat structure, whereby the ß5 and ß10 strands form
counterparts. The precise organization of the other CCC regions
is currently lacking. Yet, fruitful insights were recently obtained
by modeling approaches building on the crystallized structures of
AdiC (arginine/agmantine antiporter) and ApcT (broad-specific
amino acid (aa) transporter), two related members of the APC
superfamily (Somasekharan et al., 2012). Exploiting these data
resulted in important structural insights concerning the organi-
zation of the TM and the translocation pathway as summarized
in the following.
TRANSMEMBRANE DOMAINS: STRUCTURAL
ORGANIZATION, ION TRANSLOCATION AND BINDING OF
LOOP DIURETICS
Net transport of KCCs and NKCCs occurs usually at a stoichio-
metric ratio of 1K+:1Cl− and 1Na+:1K+:2Cl−, respectively. The
mechanism mediating coupled translocation of ions is not yet
known. Concerning NKCCs, Hass and coworkers proposed an
alternating access model with ordered binding and glide symme-
try (Lytle et al., 1998; Payne, 2012). In this model, the extracellular
ions bind in a determined order (Na+-Cl−-K+-Cl−) to an open-
to-out (apo) state. The substrate bound state evolves to a fully
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occluded state to prevent diffusion of substrates. A conforma-
tional change causes transition to an inward-facing state, releasing
the ions in the same order in which they were bound. The empty
transporter returns back to the outward-facing state through a
fully occluded state. Similar models were proposed for other
crystallized members of the APC superfamily transporters such
as AdiC and ApcT (Krishnamurthy et al., 2009; Kowalczyk et al.,
2011). Structurally, these proteins display a twofold symmetry
with TMs 1–5 and TMs 6–10 orientated in an inverted repeat
structure (5+5 TMs). This organizational principle of two sim-
ilar but inverted structural elements impart a pseudo-symmetry
that provides a structural basis for the transport according to
the alternative access model with outward- and inward-facing
orientations (Kowalczyk et al., 2011). According to this model,
TM11 and TM12 are located outside of this structure (Abramson
and Wright, 2009; Fang et al., 2009; Shaffer et al., 2009; Kowalczyk
et al., 2011). In an hsNKCC1 3D homology model, generated
by the Forbush’s group using the structures of AdiC and ApcT
as a template, the translocation pathway is lined up with TMs
1, 3, 6, 8, and 10, which are surrounded by the other helices.
During transition from the outfacing structure to the occluded
state, TM6 and TM10 appear to rotate and bend against TMs
1, 3, and 8 (Somasekharan et al., 2012). According to this 3D
model, the translocation pocket forms at the level of Met382
(TM3) and TM6 (Payne, 2012). Intracellular release of substrates
could be controlled by the intracellular loop (ICL) 1 that creates
a flexible intracellular gate (Payne, 2012; Somasekharan et al.,
2012).
To verify the 3D homology model, Somasekharan et al.
(2012) performed cysteine and tryptophan scanning mutagenesis
of the highly conserved TM3 that lines up the translocation
pathway (Figure 1). At the extracellular side of the transloca-
tion cavity, Met382 and Tyr383 are part of the extracellular
gate, whereby the hydroxyl group of Tyr383 seems to take part
in ion coordination. Interestingly, Tyr383 is highly conserved
among vertebrate NKCC1 and NKCC2 whereas the K+ indepen-
dent Na+-Cl− cotransporter NCC exhibits a histidine instead of
tyrosine (Figure 1). Within the translocation pathway, mutation
of Ala379 to Cys, Leu, or Trp results in loss of function and
mutation to Gly and Ser leads to decreased ion affinities. These
data indicate an important role of these residues in ion translo-
cation. Further residues like Ala375 and Asn376 are predicted
to be exposed to the pore of hsNKCC1. At the intracellular
side, Phe372 has a function in ion binding, and Ile368 and
Gly369 are necessary for ion coordination at the cytoplasmic
site. Interestingly, a tryptophan substitution of Phe372 affects
the affinity for Na+, but not for K+, whereas a substitution of
Val378 only affects K+ affinity. This observation supports the
suggestion of the alternating access model with gradual bind-
ing of Na+-Cl−-K+-Cl− (Lytle et al., 1998). The hsNKCC1 3D
model also suggests that the bumetanide binding site is near
the intracellular end of the pocket. Mutation of the intracellular
gate residues Phe372 and Ile371 strongly decreased bumetanide
binding and mutation of the extracellular gate residue Met382
completely blocked bumetanide binding (Somasekharan et al.,
2012). These data are in line with previous observations that
binding of bumetanide is dependent on the presence of all
three ions and competes with the binding sites of one of the
two Cl− ions (Forbush and Palfrey, 1983; Haas and Forbush,
1986).
Further support for the 3D homology structure came from
cysteine-scanning mutagenesis of the highly conserved TM6 that
also lines up the translocation pathway (Dehaye et al., 2003;
Payne, 2012). Both TM1 and TM6, which are counterparts
in the two inverted repeat structures, consist of α-helices that
are interrupted in the proximity of the binding site result-
ing in the α-helices TM1a+b and TM6a+b (Krishnamurthy
et al., 2009). This binding site creates a polar environment for
the coordination of the substrates due to main-chain hydro-
gen bonding (Yamashita et al., 2005). A cysteine mutation of
the highly conserved Pro496 near the end of the interrupted
helix or the Ala497 that is conserved among vertebrate NKCC1
and NKCC2 (equivalent to Pro487 and Ala488 in the experi-
mentally analyzed rat NKCC1 (rnNKCC1); Figure 1) disrupts
FIGURE 1 | Alignment of TM3 and TM6 of vertebrate NKCCs, NCCs
AdiC, and ApcT. (A) The alignment depicts residues involved in ion
translocation in TM3. These residues are Met382, Tyr383 at the
extracellular site (blue asterisk), Ala375, Asn376, Val378, and Ala379
building the translocation pore (red asterisk), and Phe372, Ile368, and
Gly369 at the intracellular site (black asterisk). Residues that are
important for Na+ affinity (circle) and K+ affinity (triangle) are also
marked. (B) The alignment of TM6 highlights residues Pro496 and
Ala497 whose mutation to Cys disrupts ion transport, and an
Ala492Cys mutation that is sensitive to cysteine-modifying reagents. hs
(Homo sapiens), rn (Rattus norvegicus), md (Monodelphis domesticus),
gg (Gallus gallus), sa (Squalus acanthias), oc (Oryctolagus cuniculus).
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function indicating a role in the translocation pathway (Dehaye
et al., 2003; Payne, 2012). A cysteine mutation in the mid-
dle of the TM6a helix (Ala492Cys; Ala488 in rat NKCC1) is
sensitive to cysteine-modifying reagents in the presence but
not in the absence of extracellular Cl− (Dehaye et al., 2003).
This could be due to different conformations of TM6 in the
outward-facing and the occluded state of hsNKCC1 (Payne,
2012).
Based on the crystal structure of AdiC, closing of the
extracellular gate might be due to a small rotation of TM6
and TM10 (Monette et al., 2014). To analyze the rotation
and translocation, cysteine-mutations were inserted into TM10
(Pro676Cys, Ile677Cys, Asn680Cys) and into TM11 and TM12
(Ile730Cys, Ala734Cys, Ala735Cys, Trp733Cys). All three TMs
are likely in close proximity. Disulfide cross-linking of TM10
and TM12 via Pro676Cys-Ala734Cys and Ile677Cys-Ala734Cys
inhibits ion transport consistent with a movement of TM10
during occlusion (Monette et al., 2014). In contrast, cross-
linking of Pro676Cys and Ile730Cys increased transport activ-
ity of hsNKCC1, probably due to a “lock” in an activated
state. Likely, this activated state is physiologically induced by
N-terminal phosphorylation (Monette et al., 2014). In the inac-
tive state, Asn680Cys-Trp733Cys, Asn680Cys-Ala734Cys, and
Ile677Cys-Ala735Cys cross-link to each other supporting their
close proximity. As Asn680 is one helix further in the membrane
compared to Ile677, Monette et al. (2014) suggested an inward
movement of less than 5 Å of TM12 relative to TM10 during
activation.
Previous biochemical analyses mainly exploited differences
in functional properties between orthologous species or splice
variants of NKCCs and NCCs to identify residues that are impor-
tant for ion transport and affinities for diuretics (Isenring and
Forbush, 2001; Payne, 2009, 2012). Thiazide-type diurectics and
loop diuretics like furosemide and bumetanide are important
pharmacological inhibitors of CCCs and frequently used to char-
acterize the contribution of CCCs to physiological processes.
Chimera exploiting different affinities for ions and diuretics
between shark (saNKCC1) and hsNKCC1 suggested that TMs but
not the termini are responsible for the differences in affinities
(Isenring and Forbush, 1997, 2001; Isenring et al., 1998a,b,c).
TM2 was shown to influence Na+ and Rb+ kinetics, TM4
Rb+ and Cl− kinetics, and TM7 Na+, Rb+ and Cl− kinetics
(Isenring and Forbush, 1997, 2001; Isenring et al., 1998a,b,c).
In-depth analyses of TM2 demonstrated that an evolutionary
change from Ala-Leu→ Ser-Val (saNKCC1AL → hsNKCC1SV) is
responsible for altered Na+ affinity and a Gly-Thr → Met-Met
change (saNKCC1GT →hsNKCC1MM) for altered Rb+ affinity
(Isenring et al., 1998b,c; Isenring and Forbush, 2001; Payne,
2012). Similar analyses on NKCC2 splice variants (NKCC2A,
B and F), which differ in 23 aa in the TM2 and ICL1, pro-
vided hints to aa residues involved in determining Na+, Rb+
and Cl− kinetics (Gagnon et al., 2005; Giménez and Forbush,
2007). Mutagenic analyses by converting the rabbit NKCC2B
variant into the NKCC2F variant suggest, that three residues in
TM2 (rbNKCC2BATG → rbNKCC2FSVT) and three residues in
the ICL1 (rbNKCC2BTAY → rbNKCC2FMCV) are important to
turn Na+ and Cl− affinities of NKCC2B into those of NKCC2F
(Giménez and Forbush, 2007). The involvement of ICL1 suggests
that this region is also embedded in the membrane (Giménez
and Forbush, 2007). Further analyses revealed that residue 216
(saNKCC2AI216V or saNKCC2FV216I) influences Rb+ affinity,
residue 220 (saNKCC2AI220L or saNKCC2FL220I) the Na+ affinity,
and residues 240 and 249 (rbNKCC2BT240M, rbNKCC2BT249M
corresponds to saNKCC2AI216 and to saNKCC2AT225M) the
Cl− affinity (Gagnon et al., 2005; Giménez and Forbush,
2007).
Recently, a significant increase in K+ uptake over Cl− uptake
was reported for NKCCs under hypertonic condition (Gagnon
and Delpire, 2010). Thus, a large fraction of K+ can apparently
move independently of Cl−. This so called K+/K+ exchange is
more pronounced for NKCC1 than for NKCC2. A chimera of
the paralogs NKCC1 and NKCC2 revealed that ICL1 and ECL2
are important for this hyperosmotic K+/K+ exchange of NKCC1
(Gagnon and Delpire, 2010). These data indicate that TMs 2, 4,
7, ICL1, and ECL2 affect ion affinities in orthologous species.
According to the 3D homology model, these TMs and loops
surround the translocation pathway that is formed by residues of
TMs 1, 3, 6, 8, and 10 (Somasekharan et al., 2012). Therefore,
the results observed in chimera and mutants likely reflect indi-
rect structural effects on the neighboring residues forming the
translocation pathway (Payne, 2012). Unfortunately, analogous
modeling of the 3D structure of KCCs and validating biochemical
experiments are not yet available. However, Payne (1997) suggests
a role of TM2 in the binding of cations as this TM is the most
divergent transmembrane segment compared to the remaining
eleven TMs.
THE LARGE EXTRACELLULAR LOOP
In addition to short loops connecting TMs, KCCs and
NKCCs/NCCs contain an LEL of ∼100 aa residues in KCC2
and ∼70 aa residues in NKCC1, as judged from hydrophobic-
ity plots. KCC2 (Williams et al., 1999) and NKCC1 (Lytle and
Forbush, 1992) are both glycosylated proteins and several N-
linked glycosylation sites have been identified in the LEL (Hoover
et al., 2003; Paredes et al., 2006; Weng et al., 2013). Detailed
mutational analyses of these sites in KCC2 and NKCC1 have
yet to be performed, but various data suggest an important
role. Bulk deglycosylation of brain slices resulted in decreased
NKCC1 transport activity (Ye et al., 2012). Unfortunately, no
subcellular localization experiments were performed to examine
whether reduced intrinsic NKCC1 activity or surface expres-
sion caused decreased Cl−-transport. Data from the related
NCC and NKCC2 suggest a role of glycosylation in surface
expression. Mutation of two aspartate-based glycosylation sites
in the LEL of rnNCC (Asn404, Asn424) or rnNKCC2 (Asn442,
Asn452) to glutamine decreased surface targeting and thereby
transporter-mediated Cl−-flux in Xenopus oocytes (Hoover et al.,
2003; Paredes et al., 2006). Mutation of both aspartates resulted
in a stronger phenotype than mutation of a single residue.
When the same mutational analysis was performed in the
flounder NCC, which contains three N-glycosylation sites in
the LEL, elimination of all three glycosylation sites reduced
transport activity by 50% (Moreno et al., 2006). This decrease
was quantitatively different from the 90% observed for the
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rnNCC double mutant (Hoover et al., 2003), indicating a dif-
ferent organization or role of the LEL between orthologous
proteins.
In KCCs, glycosylation has only been studied in greater detail
for KCC4. Four glycosylation sites (Asn312, Asn331, Asn344, and
Asn360) are present in the LEL of the mouse KCC4 (mmKCC4)
and enzymatic characterization of mutants revealed that Asn312
and Asn360 are linked to high mannose-sugars, whereas the
two central residues, Asn331 and Asn344, contain complex-form
glycans. The latter appear critical for surface expression of KCC4,
as an Asn331Gln/Asn340Gln double mutant was retained in the
endoplasmic reticulum (Weng et al., 2013). Mutation of only one
of the aspartates was insufficient to block trafficking (Weng et al.,
2013).
Beside the aspartates, the role of cysteines within the LEL
was investigated. These cysteines are likely substrates of intra-
or intermolecular disulfide bonds. In KCCs, the LEL harbors
four cysteines which are highly conserved during evolution from
Drosophila and fish to mammals. Mutation of any of these cys-
teines rendered rnKCC2 fully inactive in HEK-293 cells without
affecting expression and surface targeting as judged by immuno-
cytochemistry (Hartmann et al., 2010). This loss of transport
function presumably reflects formation of erroneous disulfide
bridges. Similar results were obtained for compound cysteine
mutants. The same mutations, however, did not abolish transport
activity of mmKCC4, the closest paralog (Hartmann et al., 2010).
The LEL displays a higher sequence divergence (44.8%) between
KCC2 and KCC4 than between the entire transporters (28%).
Different requirement of cysteines might thus reflect distinct
structural organization of their LELs. Swapping the LEL between
the two paralogs revealed that KCC4 requires its own LEL to be
transport active, whereas the KCC2 backbone tolerates LELKCC4,
as this chimera exhibits unchanged transport activity (Hartmann
et al., 2010). These data suggest a different overall structural
organization of KCC2 and KCC4 and a functional cross talk of
the LEL with other, so far unknown regions of the transporter.
Diverging data were obtained for the role of cysteines in the
LEL of NKCC1 from different species. Mutational analysis of
five highly conserved cysteines in the LEL of saNKCC1 demon-
strated their requirement for transport activity. Substitution of
any of them by glycine abolished transport activity (Jacoby et al.,
1999). In contrast, substitution of four cysteines by serine in
the LEL of hsNKCC1 decreased transport activity by only 20%
(Somasekharan et al., 2013). Both studies were performed in
HEK-293 cells and the different results are difficult to reconcile.
They might either reflect different tolerance to the chosen substi-
tutions (glycine vs. serine) or a difference between single substi-
tutions (saNKCC1) and a quadruple mutant (hsNKCC1). Finally,
species-specific differences are also possible. Clearly, further com-
parative studies are required to settle this issue. It might also be
interesting to study the role of these cysteines in other family
members to gain insight into the evolutionary conservation of
their functional role in the different family branches. To sum up,
the organization and role of the LEL shows an amazing diversity
between orthologs and paralogs. This is evidenced by the different
functional consequences of aspartate mutations in the ortholog
rat and flounder NCC, and by the different effect of cysteine
mutations in the ortholog human and flounder NKCC1, or in the
paralog rat KCC2 and KCC4.
The LEL was also thought to be involved in binding of
diuretics. This was based on studies on chimera between fam-
ily members with different affinities for the respective diuretic
(Hoover et al., 2003; Castañeda-Bueno et al., 2010; Hartmann
et al., 2010). As pointed out above, 3D model guided mutational
analyses strongly argue for a binding of diuretics to the translo-
cation pocket (Somasekharan et al., 2012). Thus, the observed
changes in binding of diuretics after manipulations in the LEL
likely reflect an indirect effect via changes in overall structural
organization.
CONSTITUTIVE TRANSPORT ACTIVITY AND THE ISO
DOMAIN
A defining feature of KCC2 is its high constitutive transport
activity under isotonic conditions (Payne, 1997). This is essential
to maintain a low (Cl−)i in neurons. All other KCCs show
low transport activity under isotonic conditions and require cell
swelling for substantial transport activity. Several studies there-
fore attempted to identify the aa sequence in KCC2 that confers
this unique functional property. In his original paper describing
constitutive activity of KCC2 in HEK-293 cells, Payne alluded
to a stretch of 41 aa residues in the C-terminus (KCC2b aa
929–970), as it was specific to KCC2 in sequence alignments
of mammalian KCCs (Payne, 1997, 2009). An expanded align-
ment including recently obtained sequences from other vertebrate
groups (Figure 2), however, reveals that this sequence is partially
present in fish, birds and marsupial KCC4 as well. During evo-
lution of placentalia, this sequence became part of an intron and
thereby ceased to be translated at the ribosomes (Antrobus et al.,
2012).
A detailed analysis using KCC2 and KCC4 mutants and
chimera in Xenopus oocytes identified a 15 residue long sequence
that conferred isotonic transport activity to KCC4 (Mercado et al.,
2006). This 15 aa long sequence was called the ISO domain
and is positioned between aa 1021–1035 in the rnKCC2b and
thus proximal to the 41 aa residues, suggested by Payne (1997).
The residues are encoded by exon 23, which is highly divergent
in KCCs. A parallel study using the same approach obtained
similar results, yet questioned whether this domain is required
for isotonic activity (Bergeron et al., 2006). This conclusion was
based on the fact that the absence of the ISO segment in KCC4
wild-type (wt) or KCC2/KCC4 chimera did not abolish transport
activity under isotonic conditions.
A recent study in neurons provided compelling support
for a role of aa 1022–1037 in constitutive transport activity.
Transferring this sequence to KCC4 rendered this transporter
constitutively active in hippocampal neurons, whereas its replace-
ment by the corresponding KCC4 sequence abolished KCC2
constitutive activity. An important corollary of this study was
the observation that the ISO-domain deprived KCC2 could be
activated under hypotonic conditions, similar to KCC4. Thus,
KCC2 has likely two functionally distinct domains, one KCC2-
specific ISO domain, and a second domain, likely shared with
other KCCs, conferring transport under hypotonic conditions
(Acton et al., 2012). In the future, it will become important
Frontiers in Cellular Neuroscience www.frontiersin.org January 2015 | Volume 8 | Article 470 | 5
Hartmann and Nothwang Structural organization of CCCs
FIGURE 2 | Alignment of the C-terminus of vertebrate KCC isoforms. The
alignment depicts the amino acid residues encoded by exon 22 (blue bar),
exon 23 (green bar), and exon 24 (pink bar) that are located in a part of the
C-terminus (residues 929–1047 according to rnKCC2). Exons 22 and 24 are
only present in all vertebrate KCC2 and placentalian KCC4 isoforms. The only
exception is the presence of exon 24 in gallus gallus KCC1. Alignment of exon
23 indicates a higher variability among paralogs KCC isoforms. The
phospho-acceptor sites Thr934, Ser937, and Ser940 that stimulate
KCC2-mediated transport upon phosphorylation, are indicated as asterisk.
The 15 amino acid long ISO domain located in exon 23 is indicated by a red
line. hs (Homo sapiens), rn (Rattus norvegicus), md (Monodelphis
domesticus), gg (Gallus gallus), dr (Danio rerio), xt (Xenopus tropicalis).
to study the evolution of the ISO domain, as its appear-
ance likely has implications for the emergence of fast synaptic
inhibition.
Mammalian NKCC1 and its closest paralog, NKCC2, exhibit
both transport activity under isotonic conditions. Thus, isotonic
activity is no specific trait of NKCC1 and has not been an issue in
the field. However, a recent study addressed the difference in stim-
ulation by hypertonic media between mammalian NKCC1 and
NKCC2. Hypertonic conditions increased NKCC1 ∼3-fold after
heterologous expression in Xenopus oocytes, whereas NKCC2 was
only stimulated ∼2-fold (Gagnon and Delpire, 2010). Chimera
and mutational analyses indicate that ICL1, TM2, and ECL2 of
NKCC1 contribute to osmotic sensitivity (Gagnon and Delpire,
2010). Additional work will be required to characterize the precise
interplay between these sequences and how they are affected by
osmotic change.
OLIGOMERIZATION
Both KCC2 and NKCC1 form homo-oligomeric structures as
evidenced by multiple biochemical and functional interaction
studies (Moore-Hoon and Turner, 2000; Casula et al., 2001;
Starremans et al., 2003; Simard et al., 2004; Blaesse et al.,
2006; Parvin et al., 2007; Pedersen et al., 2007; Simard et al.,
2007; Casula et al., 2009; Warmuth et al., 2009; Monette and
Forbush, 2012). Monomers, dimers, and at least tetramers have
been reported for KCCs, and monomers as well as dimers
for Na+-dependent cotransporters (Starremans et al., 2003;
Blaesse et al., 2006; Mahadevan et al., 2014). Additionally,
both transporters have been suggested to oligomerize with
other family members as well (Caron et al., 2000; Casula
et al., 2001; Simard et al., 2007; Wenz et al., 2009). How-
ever until now, hetero-oligomerization has only been observed
in heterologous expression systems. We will therefore limit
our review to homo-oligomeric organization. The two major
questions pertaining to oligomerization relate to its mecha-
nisms and its requirement for transport activity. Currently,
the answers to these questions appear more advanced for
NKCC1.
Yeast two-hybrid studies revealed that the cytosolic C-termini
of hsNKCC1 and hsNKCC2 contain self-interacting sequences
(Simard et al., 2004). It was, however, unclear, whether they
were important for intramolecular or intermolecular interac-
tions. Elegant biochemical cross-linking studies with exchanges
between the C-terminus of rnNKCC1 and the non-NKCC1 family
members NKCC2, NCC, or CIP1 demonstrated the requirement
of the C-terminal aa residues 751–998 for homo-dimerization
of NKCC1 in HEK-293 cells (Parvin et al., 2007). In contrast,
removal of the N-terminus did not affect dimerization (Parvin
et al., 2007). Exploiting further this chimeric approach, the
major interaction region was delineated to aa residues 806–814,
with aa 842–912, aa 825–841, and aa 815–825 also supporting
dimerization (Parvin and Turner, 2011). Substitution of any of
four NKCC1-specific aa residues between 806–814 by the cor-
responding NKCC2 residues resulted in significantly impaired
dimerization (Parvin and Turner, 2011). The involvement of the
C-terminus in dimerization is supported by structural data of
the archean CCC, which forms dimers in solution. The struc-
ture of the crystallized C-terminus suggests a relatively small
hydrophilic dimer interface in which residues of α helices 1
and 2 in one subunit are in proximity to residues located in
the loop connecting the β-strands 5 and 6 in the second sub-
unit, and vice versa (Warmuth et al., 2009). An alanine sub-
stitution of Arg627 disrupts dimerization of maCCC probably
due to a loss of salt bridges that were formed by glutamate
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residues (e.g., Glu550 and Gl551) in α helix 2 of the adjacent
C-terminus (Warmuth et al., 2009). Of note, mapping of the
rnNKCC1 aa residues 806–814 to the archean CCC revealed
that they are close to the putative dimer interface (Parvin and
Turner, 2011). Thus, both experimental and structural data con-
cur on C-terminus mediated dimerization of the Na+-dependent
cotransporters. This conclusion is further supported by the obser-
vation of fluorescence resonance energy transfer (FRET), occur-
ring between co-expressed NKCC1 clones tagged with CFP or YFP
at the C-terminus (Pedersen et al., 2007; Monette and Forbush,
2012).
Concerning KCCs, first insights for oligomerization came from
a pioneering study of the Alper’s group. They observed that an N-
terminal truncated and transport inactive KCC1 variant, which
was present at the surface, suppressed transport activity of co-
expressed KCC family members in a dose-dependent manner in
Xenopus oocytes (Casula et al., 2001). Subsequent work demon-
strated that deletion of either the cytoplasmic N- or C-terminus
did not impede oligomerization with full length KCC1, based
on cross-linking studies in Xenopus oocytes and HEK-293 cells
(Casula et al., 2009). These data point to the involvement of TMs
for oligomerization. Unfortunately, a construct encompassing
only the TMs and their connecting loops was not stringently
tested. Its analysis would have been important to rule out the
possibility that the observed oligomerization in the absence of
either the N- or the C-terminus is merely reflecting the fact that
either of the cytoplasmic regions is sufficient for oligomeriza-
tion. Such a construct, however, is likely not well expressed at
the surface. Another study using the yeast two-hybrid system
observed dimerization of the full length C-terminus of KCC2 or
KCC4 (Simard et al., 2007). In contrast, the C-termini of KCC1
and KCC3 failed to interact, similar to C-terminal fragments
of the KCC2 or KCC4, truncated by ∼100 aa residues from
either of the two termini (Simard et al., 2007). For technical
reasons, the cytoplasmic N-terminus and the TMs could not be
analyzed in this system. Finally, a biochemical study using the
rat hypothalamic cell line GT1–7 reported that removal of the
final 28 aa of KCC2 resulted in a decrease of oligomers and
an increase of monomers (Watanabe et al., 2009). Whether this
decrease was due to lack of residues involved in dimerization
or due to altered overall conformational changes of the trun-
cated C-terminus was not investigated. Taken together, these
data best fit a model, where oligomerization occurs via TMs
and C-terminal sequences. Involvement of the C-terminus is in
agreement with the aforementioned structural analysis of the
C-terminus of the archean CCC (Warmuth et al., 2009). Con-
tribution of the TMs is supported by the structure of AdiC
(Fang et al., 2009; Gao et al., 2009). According to the crystal
structure of this transporter at 3.2 Å resolution, TMs 11 and
12 provide the homodimeric interphase. Future studies should
therefore address whether these two TMs fulfill the same function
in KCCs. This would contrast the C-terminal mediated oligomer-
ization in the Na+-dependent branch of CCCs. Yet, as pointed
out by the Isenring’s group, interaction data are often difficult
to interpret, as mutations and truncations may disrupt long-
range interactions, thereby inducing erroneous conformations. In
addition, biochemical analysis of oligomerization is challenged
by the observation of rapid formation of KCC aggregates during
purification, especially of overexpressed KCC2 in heterologous
systems (Medina et al., 2014). These high molecular aggregates
are for yet undefined reasons resistant to SDS (Medina et al.,
2014). Both these features may lead to false negative and positive
results.
With respect to the question whether homo-oligomerization is
required for transport activity, three possibilities have to be distin-
guished: (i) Each subunit itself is a self-contained transporter and
oligomerization is not required; (ii) Individual subunits mediate
transport, but require oligomerization to adopt a transport active
configuration; and (iii) Cooperation of both subunits is required,
and substrate binding occurs to more than one subunit. The
analysis of a concatemeric expression construct of NCC, consist-
ing of a wt and a transport-impaired mutant, linked by a short
spacer, revealed no change in transport activity, compared to a
concatemer consisting of two wt NCCs (de Jong et al., 2003).
Concatemers of transport impaired NKCC2 or AdiC transporter,
another member of the APC transporter superfamily, with the
respective wt transporter showed transport activities amounting
to∼50% of a purely wt composed concatemer (Starremans et al.,
2003; Fang et al., 2009). As transport activity was in neither case
completely abolished, each individual NCC or NKCC2 polypep-
tide likely mediates substrate transport across the membrane,
although an interaction of wt subunits from different tandem
constructs cannot be excluded. FRET studies also demonstrated
homomeric NKCC1 in the plasma membrane (Pedersen et al.,
2007; Monette and Forbush, 2012). The previously reported
functional interaction of different co-expressed splice variants of
NKCC2 is therefore likely not reflecting cooperation of individual
subunits for ion transport but rather due to altered traffick-
ing or changes in functionally important interactions with the
cytoskeleton (Plata et al., 1999). Whether dimerization of Na+-
dependent transporters is required for transport activity and
whether dimerization is regulated is presently unknown. FRET
analyses and cross-linking analyses revealed a large movement
of NKCC1 C-termini during activation processes. Blocking phos-
phatase 1, or exposure to low Cl− hypotonic or zero K+ isotonic
media stimulated NKCC1 transport activity, but decreased the
intermolecular FRET signal (Monette and Forbush, 2012). This
is likely due to a movement of TM12, which participates in
dimerization, during activation of NKCC1 (Monette et al., 2014).
The observed decrease in intermolecular FRET signals between
the interacting C-termini during activation of NKCC1 indicates a
loosening of the dimer during transport.
An important issue in the field is whether monomeric KCC2
is transport active or not. Several studies suggest that only
oligomeric KCC2 is transport active. In the brainstem, an increase
of higher molecular weight KCC2 complexes in SDS-PAGE paral-
leled activation of the transporter in auditory brainstem nuclei,
suggesting a link between KCC2 oligomerization and trans-
port activity (Blaesse et al., 2006). In contrast, another analysis
using PFO-PAGE electrophoresis demonstrated oligomeric KCC2
already at P2 and revealed a tendency of KCC2 to form aggre-
gates at high concentrations in heterologous expression systems
(Uvarov et al., 2009). If aggregation holds true for native brain tis-
sue as well, the developmental increase of high molecular weight
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forms of KCC2 in SDS-Page may partially be caused by the devel-
opmental increase in protein amount. Alternatively, the higher
order KCC2 complexes observed in the PFO-PAGE might reflect
association of the transporter with interacting proteins such as
Neto2 or kainate receptors (see below). This type of hetero-
oligomerization is likely lost in SDS-PAGE. Other studies reported
a decrease of oligomeric KCC2 under conditions of decreased
transport activity (Watanabe et al., 2009; Mahadevan et al., 2014).
The dominant-negative effect of the N-terminal truncated, trans-
port inactive KCC1, which does not affect surface expression of
wt KCCs, supports the notion that oligomeric KCC2 is the only
transport active form (Casula et al., 2001). Finally, Neto2, a KCC2
interaction partner, is required for KCC2-mediated Cl− extrusion
and associates preferentially with oligomeric KCC2 (Ivakine et al.,
2013).
Due to the lack of crystal structure of an entire CCC protein,
it is unclear why oligomerization should be required for transport
activity. A clue might come from the observation that movement
of TM12 is involved in inducing a transport active configuration
in NKCC1 (Monette et al., 2014). According to the AdiC model,
this TM can partake in dimerization as well. If this holds true,
dimerization might help to appropriately position and move this
TM in order to regulate transport activity. The assumption of
oligomeric KCC2 as the sole transport active form does by no
means preclude self-contained transporter subunits, as it was
suggested for the Na+-dependent transporters and AdiC (Fang
et al., 2009). Further studies including concatemers should be
performed for KCC2 to settle this issue.
The correlation of oligomeric state and transport activity in
combination with the variable ratio of monomeric to oligomeric
form raised interest in mechanisms regulating oligomeriza-
tion. The tyrosine kinase inhibitor genistein caused a signifi-
cant shift towards monomeric KCC2 in GT1–7 cells, suggesting
that tyrosine phosphorylation promotes KCC2 oligomerization
(Watanabe et al., 2009). However, substitution of Tyr1087 by
Asp, which mimics phosphorylated tyrosine, recapitulated the
genistein effect. These results are therefore difficult to inter-
pret and might indicate that the genistein-sensitive tyrosine
kinase interacts rather with another kinase and not directly
with KCC2. This notion is supported by the observation that
both the tyrosine phosphorylation blocking agent genistein and
the phospho-mimetic KCC2 mutant Tyr1087Asp caused a more
positive reversal potential of GABA (Watanabe et al., 2009).
Note, however, that the genistein and KCC2 Tyr1087Asp exper-
iments were performed in different cell types (hippocampal
neurons vs. GT1–7 cells), which might entail different effects
of tyrosine phosphorylation. Finally, a recent analysis indi-
cates that the tyrosine phosphorylation of KCC2 leads to an
increased degradation of the transporter, both in HEK-293
cells and hippocampal neurons (Lee et al., 2010). Unfortu-
nately, the role of tyrosine phosphorylation for oligomeriza-
tion was not addressed in this study. The total amount of
KCC2 parallels tyrosine phosphorylation of the transporter dur-
ing brain development, as probed by the anti-phosphotyrosine
antibody 4G10 (Stein et al., 2004). Tyrosine phosphorylation
of KCC2 therefore does not correlate with the reported devel-
opmental increase of the oligomer to monomer ratio of KCC2
(Blaesse et al., 2006). Taken together, regulation of KCC2
oligomerization by tyrosine phosphorylation remains an open
issue.
Localization to membrane microdomains may represent
another factor involved in oligomerization. Two studies observed
KCC2 in both membrane rafts and non-rafts (Hartmann et al.,
2009; Watanabe et al., 2009). Analysis of the developing mouse
brainstem revealed that monomeric KCC2, which prevails in
the perinatal brainstem, mainly localized to membrane rafts.
In the adult mice brainstem, KCC2 exists as monomers and
oligomers and was recovered in both membrane rafts and non-
rafts. The correlation between the developmentally increase of
oligomeric KCC2 and the appearance of the transporter in non-
rafts suggests that oligomeric KCC2 partitions to non-rafts. Yet,
further biochemical and high-resolution microscopy are required
to clarify the role of membrane rafts for KCC2 activity and
organization. Finally, kainate receptors form high molecular
weight hetero-oligomeric complexes with KCC2 (Mahadevan
et al., 2014). Intriguingly, in mice lacking GluK1/2, an increase
of monomeric KCC2 and a decrease in oligomeric KCC2 was
observed (Mahadevan et al., 2014). It thus appears that kainate
receptors influence the monomer to oligomer ratio of KCC2.
It is currently unknown whether the interaction assists forma-
tion or promotes stability of KCC2 oligomers. It will be there-
fore interesting to study whether kainate receptors and KCC2
already interact in the trafficking pathway or only at the plasma
membrane.
PHOSPHORYLATION
Phosphorylation of the transporters has proven to be a power-
ful regulatory mechanism. Several excellent reviews have been
recently published on this issue (Kahle et al., 2013; Alessi et al.,
2014; Medina et al., 2014) and we will therefore focus on
general principles, neglected issues, and open questions. Initial
data proposed an elegant model in which KCC2 and NKCC1
activities were reciprocally regulated by phosphorylation. In
Xenopus oocytes, coexpression of WNK3 (with no lysine kinase
3) with CCCs resulted in activation of NKCC1 and inacti-
vation of KCC1 and KCC2 (Kahle et al., 2005). Subsequent
analysis demonstrated that the action of WNK family mem-
bers in combination with their functionally redundant down-
stream targets STE20/SPS1-related proline/alanine-rich kinase
(SPAK) and oxidative stress responsive kinase (OSR1) results
in phosphorylation of a cluster of threonines and serines in
the N-terminus of NKCCs and NCCs (Darman and Forbush,
2002; Vitari et al., 2006; Richardson et al., 2008; Kahle et al.,
2013; Alessi et al., 2014). The number of these phosphory-
lated aa residues varies between different family members, as
they are not strictly evolutionary conserved among paralogs
and orthologous family members (Figure 3). Phosphorylation
of these residues is triggered by hypotonic low Cl− conditions
or a reduction in cell volume and results in stimulation of
NKCC/NCC transport activity. For NKCC1, this activation was
shown to be caused by conformational changes via a long-
range interaction between the N-terminal phospho-site and other
parts of the transporter (Darman and Forbush, 2002; Pedersen
et al., 2007; Monette and Forbush, 2012). In addition to this
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FIGURE 3 | Alignment of the N-terminus of vertebrate NKCC and
NCC isoforms. WNK-SPAK/OSR1 mediated phosphorylation of several
threonine and serine residues that are located in a part of the
N-terminus (residues 199–253 according to hsNKCC1). saNKCC1:
Thr175, Thr179, Thr184 Thr189, Thr202 are indicated as asterisk;
ocNKCC2: Thr99, Thr104, Thr117, Ser126 are indicated as hashes;
hsNCC: Thr46, Thr55, Thr60, Ser73, Ser91 are indicated as paragraphs.
hs (Homo sapiens), rn (Rattus norvegicus), md (Monodelphis
domesticus), gg (Gallus gallus), sa (Squalus acanthias), oc (Oryctolagus
cuniculus).
intrinsic activation of NKCC1, a recent analysis of NCC revealed
that phosphorylation of these residues increases surface expres-
sion by reducing internalization (Rosenbaek et al., 2014). Note-
worthy, a serine/threonine phospho-dead NKCC1 mutant was
reported to be expressed at the cell surface of HEK-293 cells
(Somasekharan et al., 2013). Although no quantitative analy-
sis of surface expression was performed, the result indicates
phosphorylation-independent surface expression (Somasekharan
et al., 2013). This observation raises the questions whether the
consequences of N-terminal phosphorylation are different for
paralogs NKCC/NCC isoforms and whether specific phosphory-
lation codes exist to trigger either intrinsic activation or surface
expression.
In contrast to NKCC/NCC, regulation of KCCs by the WNK-
SPAK/OSR1 signaling pathway involves the N-terminal Thr6
(numbering belongs to rnKCC2a) and Ser96 (KCC3A specific),
and the C-terminal Thr906 and Thr1007 (numbering belongs to
rnKCC2b) (Rinehart et al., 2009; Inoue et al., 2012; Kahle et al.,
2013; Melo et al., 2013; de Los Heros et al., 2014). Thus, the
opposite action of the WNK-SPAK/OSR1 signaling system on
the two CCC branches is associated with a strikingly different
positioning of their phospho-sites. A recent elegant analyses using
a NKCC1 dimer with a C-terminal incorporated FRET probe
and chemical cross-linking studies demonstrated that the N-
terminal phosphorylation in NKCC1 results in a movement of
TM10 and TM12 relative to each other and a movement of the
C-terminus (Monette and Forbush, 2012; Monette et al., 2014).
It is thus not excluded that phosphorylation of N-terminal or
C-terminal phospho-sites affects similar regions in KCC2 and
NKCC1.
This simple and appealing model of a reciprocal effect of
phosphorylation of NKCCs/NCC and KCCs, however, has under-
gone substantial modifications. Recent data identified additional
phospho-sites and revealed a complex role of phosphoryla-
tion for KCC2 function. Analysis of the evolutionary highly
conserved Tyr903 and Tyr1087 revealed that dephosphorylation
of both sites (mimicked by mutation to Phe) increased cell
surface stability (Lee et al., 2010). Mutation of either of the
two residues had no effect. This is in agreement with the
unchanged transport activity of a Tyr1087Phe mutant in Xeno-
pus oocytes (Strange et al., 2000). A phospho-mimetic KCC2
Tyr1087Asp mutant is transport inactive in Xenopus oocytes
(Strange et al., 2000), GT1–7 cells (Watanabe et al., 2009), and
neurons (Akerman and Cline, 2006; Pellegrino et al., 2011).
As this mutant displays normal cell surface expression (Strange
et al., 2000; Akerman and Cline, 2006), Tyr1087 likely influences
the intrinsic activity. Clearly, further studies are required to
fully understand the role of tyrosine phosphorylation for KCC2
function.
Importantly, phosphorylation can also activate KCC2. Phos-
phorylation of Ser940 increases surface expression, KCC2 trans-
port function (Lee et al., 2007), and membrane clustering
(Chamma et al., 2012). Lee et al. (2007) also identified another
KCC2-specific serine residue, Ser728, whose mutation to ala-
nine resulted in increased KCC2 transport activity. It will
therefore be interesting to analyze this phospho-site in more
detail. Finally, mutational analysis of Ser937 or the neighbor-
ing T934 showed that phospho-mimetic substitutions increased
KCC2 transport activity as well (Weber et al., 2014). Surface
expression analyses suggest that their phosphorylation results
in intrinsic activation of KCC2, which would contrast and
complement the activation mechanism by phosphorylation of
Ser940. These recent data demonstrate that phosphorylation
can both activate and inactivate KCC2 mediated transport.
In this respect, it is interesting to note that phosphorylation
of Tyr903, Thr906, Thr1007, Tyr1087, which are evolutionary
highly conserved in KCCs, are all associated with inactivation.
In contrast, the three phospho-sites Thr934, Ser937, and Ser940,
which increase KCC2-mediated transport upon phosphorylation,
are encoded by exon 22 (Figure 2). This exon is exclusively
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expressed in the vertebrate KCC2 and non-placentalian KCC4
isoform (Payne, 2009; Weber et al., 2014). Since phosphorylation
of these aa residues results in increased KCC2 activity, they
might provide an adaptive and fast reacting safety system to
cope with challenging situations in the nervous system. The
high transport activity associated with phosphorylation of these
residues, however, comes with high metabolic costs and com-
promises effective responses to volume or intracellular pH
changes (Kaila, 1994; Payne, 2009; Kaila et al., 2014). Switching
between basal and high transport activity might therefore be
advantageous, as it also economizes on the energetic costs of
protein synthesis. Finally, the different conservation of phospho-
sites across paralogs likely assisted subfunctionalization of new
paralogs.
The absence of the three phospho-sites Thr934, Ser937, and
Ser940 in the placentalian KCC4 also sounds a note of cau-
tion to the interpretation of the frequently used C-terminal
chimera between KCC2 and KCC4. The observed differences
might merely reflect presence or absence of these regulatory sites.
It also has to be kept in mind that most data concerning KCC2
phosphorylation were obtained from in vitro systems such as
cell culture or slices. Their precise in vivo roles have therefore
still to be explored. This will likely require transgenic mice
with mutated phospho-sites. Another important research field
in the future will be the functional characterization of various
native phospho-sites identified by mass spectrometry. Accord-
ing to publically available databases such as PhosphoSitePlus
and Phosida, numerous phospho-sites scattered along the entire
polypeptide have been observed for both NKCC1 and KCC2.
Their analyses might help to identify whether NKCC1 contains
C-terminal located regulatory phospho-sites similar to KCC2.
We also still lack the staurosporine (and likely N-ethylmaleimide
(NEM)) sensitive phospho-site. Both agents have been implicated
in KCC2 activation, but their precise target has remained elusive
(Lauf and Adragna, 2000; Lauf et al., 2001, 2006; Khirug et al.,
2005).
An emerging issue is the cross talk of phospho-sites with other
sites in CCC and their context dependent action. In saNKCC1,
a Thr202Glu mutant could be activated by preincubation in low
Cl− hypotonic medium, but not by preincubation in hypertonic
medium, and became even inactivated upon transition from a low
Cl− hypotonic medium to hypertonic medium, contrary to wt
NKCC1 (Darman et al., 2001). These data suggest that alternative
activation modalities differentially affect a given phospho-site.
Furthermore, this phospho-site is altering the phosphorylation
of Thr184/Thr189 in saNKCC1 (Darman et al., 2001). In KCC2,
phosphorylation of Ser940 was affected by two KCC2 variants,
Arg952His and Arg1049Cys, which were recently genetically
linked to human idiopathic generalized epilepsy (Kahle et al.,
2014). Finally, action of the broad band serine/threonine kinase
inhibitor staurosporine and NEM was shown to be a function
of the phosphorylation state of Thr934 or Ser937 (Weber et al.,
2014). Whereas both agents activated wt KCC2 or alanine mutants
of these two aa residues in HEK-293 cells, their effect reversed for
aspartate mutants. Identification of the interplay between differ-
ent phospho-sites will be important with respect to the concept of
pharmacotherapeutical targeting of KCC2 phosphorylation. This
approach requires comprehensive understanding of the interplay
between different phospho-sites under varying conditions.
SUMMARY
Recent years have witnessed important progress in our under-
standing of the structural organization of the CCC family. The
initially proposed topology of 12 TMs and two intracellularly
located termini was confirmed and valuable information about
molecular mechanisms of ion translocation and regulation of
transport activity has been gathered. Noticeable, 3D modeling
based on the structure of the related AdiC and ApcT, as pioneered
by the Forbush’s group, provides a promising tool to bypass
the lack of a crystal structure for any of the family members.
The 3D homology model confirmed the previously proposed
alternating access model in which ions bind in an ordered way
to the apo state. A conformational change via the intermediate
fully occluded state leads to an ordered release of the ions in
the inward-facing state (Lytle et al., 1998; Kowalczyk et al., 2011;
Somasekharan et al., 2012). According to the model, the translo-
cation pathway is lined up with TMs 1, 3, 6, 8, and 10. Biochemical
cross-linking and FRET analyses of the TMs 3, 6, 10 and 11/12
confirm this model. The successful application of this approach
so far holds the promise that the translocation mechanism can
be resolved through the interplay between structural modeling
and biochemical approaches. However, we have to bear in mind
that inferring functional properties from data obtained for a
different family member is difficult, as many differences have
already been reported between paralogs and orthologous CCC
family members.
The cytoplasmic termini are mainly involved in regulation of
transport activity via oligomerization, phosphorylation, sorting,
and membrane expression. X-ray analyses of the archean maCCC
revealed that the C-terminus consists of a mixed α/ß fold and
two structurally related subdomains (Warmuth et al., 2009). The
C-terminus forms a small hydrophilic dimer interface in which
residues of α helices 1 and 2 in one subunit are in proximity
to residues located in the loop connecting the β-strands 5 and
6 in the second subunit, and vice versa. Oligomerization via
the C-terminus was demonstrated for vertebrate NKCCs/NCC.
Concerning KCCs, our current picture is less clear. Both the
C-terminus and TMs have been implicated in oligomerization
and settling this issue requires further studies. As these anal-
yses have to account for the inherent difficulties in biochemi-
cal analysis of KCC2 in heterologous expression system, FRET
based approaches hold great promises. Finally, phosphoryla-
tion has emerged as a key regulatory mechanism. Initially, a
reciprocal regulation with KCCs being inactivated and NKCCs
being activated via phosphorylation was observed. Yet, it has
become evident, that at least for KCC2, phospho-regulation
is more complex, including activation by phosphorylation and
functional cross talk between different phospho-sites. Interest-
ingly the three residues Thr934, Ser937, and Ser940, involved in
phosphorylation-mediated activation, are situated in an exon that
only exists in vertebrate KCC2 and non-placentalian KCC4. These
residues might therefore provide an adaptive and fast reacting
safety system to cope with challenging situations in the nervous
system.
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